ARTBIO
Oslo, NO · 4 known investors
ARTBIO develops alpha radioligand therapies (ARTs) for cancer treatment, designing target-and-molecule combinations intended to kill tumors while sparing healthy tissue. The company covers the design, manufacture, and distribution of its therapies and builds on radiation research from the University of Oslo and Norway's Radium Hospital.
Founders & leadership
RL
Roy LarsenScientific Founder
ØB
Øyvind BrulandScientific Founder
JF
Jonathan FreemanInterim CEO
MY
Margaret YuChief Medical Officer
PD
Philippe DasseChief Technical Officer
AD
Amra DemirovicChief Human Resources Officer
NH
Nicole HadasChief Legal Officer
JV
Jordi Vall-llosera FerranChief Quality Officer
Investors · 4
Frequently asked questions
- What does ARTBIO do?
- ARTBIO develops alpha radioligand therapies (ARTs) for cancer treatment, designing target-and-molecule combinations intended to kill tumors while sparing healthy tissue. The company covers the design, manufacture, and distribution of its therapies and builds on radiation research from the University of Oslo and Norway's Radium Hospital.
- Who founded ARTBIO?
- ARTBIO was founded by Roy Larsen, Øyvind Bruland.
- Who are ARTBIO's investors?
- ARTBIO's investors include B Capital Group, B4 Capital, F-Prime Capital Partners, Sofinnova Ventures.
- Where is ARTBIO headquartered?
- ARTBIO is headquartered in Oslo, NO.